Cargando…
Parameter evaluation and fully-automated radiosynthesis of [(11)C]harmine for imaging of MAO-A for clinical trials
The aim of the present study was the evaluation and automation of the radiosynthesis of [(11)C]harmine for clinical trials. The following parameters have been investigated: amount of base, precursor concentration, solvent, reaction temperature and time. The optimum reaction conditions were determine...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pergamon Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337850/ https://www.ncbi.nlm.nih.gov/pubmed/25594603 http://dx.doi.org/10.1016/j.apradiso.2015.01.002 |
_version_ | 1782481119063572480 |
---|---|
author | Philippe, C. Zeilinger, M. Mitterhauser, M. Dumanic, M. Lanzenberger, R. Hacker, M. Wadsak, W. |
author_facet | Philippe, C. Zeilinger, M. Mitterhauser, M. Dumanic, M. Lanzenberger, R. Hacker, M. Wadsak, W. |
author_sort | Philippe, C. |
collection | PubMed |
description | The aim of the present study was the evaluation and automation of the radiosynthesis of [(11)C]harmine for clinical trials. The following parameters have been investigated: amount of base, precursor concentration, solvent, reaction temperature and time. The optimum reaction conditions were determined to be 2–3 mg/mL precursor activated with 1 eq. 5 M NaOH in DMSO, 80 °C reaction temperature and 2 min reaction time. Under these conditions 6.1±1 GBq (51.0±11% based on [(11)C]CH(3)I, corrected for decay) of [(11)C]harmine (n=72) were obtained. The specific activity was 101.32±28.2 GBq/µmol (at EOS). All quality control parameters were in accordance with the standards for parenteral human application. Due to its reliability and high yields, this fully-automated synthesis method can be used as routine set-up. |
format | Online Article Text |
id | pubmed-4337850 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Pergamon Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-43378502015-03-03 Parameter evaluation and fully-automated radiosynthesis of [(11)C]harmine for imaging of MAO-A for clinical trials Philippe, C. Zeilinger, M. Mitterhauser, M. Dumanic, M. Lanzenberger, R. Hacker, M. Wadsak, W. Appl Radiat Isot Article The aim of the present study was the evaluation and automation of the radiosynthesis of [(11)C]harmine for clinical trials. The following parameters have been investigated: amount of base, precursor concentration, solvent, reaction temperature and time. The optimum reaction conditions were determined to be 2–3 mg/mL precursor activated with 1 eq. 5 M NaOH in DMSO, 80 °C reaction temperature and 2 min reaction time. Under these conditions 6.1±1 GBq (51.0±11% based on [(11)C]CH(3)I, corrected for decay) of [(11)C]harmine (n=72) were obtained. The specific activity was 101.32±28.2 GBq/µmol (at EOS). All quality control parameters were in accordance with the standards for parenteral human application. Due to its reliability and high yields, this fully-automated synthesis method can be used as routine set-up. Pergamon Press 2015-03 /pmc/articles/PMC4337850/ /pubmed/25594603 http://dx.doi.org/10.1016/j.apradiso.2015.01.002 Text en © 2015 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Philippe, C. Zeilinger, M. Mitterhauser, M. Dumanic, M. Lanzenberger, R. Hacker, M. Wadsak, W. Parameter evaluation and fully-automated radiosynthesis of [(11)C]harmine for imaging of MAO-A for clinical trials |
title | Parameter evaluation and fully-automated radiosynthesis of [(11)C]harmine for imaging of MAO-A for clinical trials |
title_full | Parameter evaluation and fully-automated radiosynthesis of [(11)C]harmine for imaging of MAO-A for clinical trials |
title_fullStr | Parameter evaluation and fully-automated radiosynthesis of [(11)C]harmine for imaging of MAO-A for clinical trials |
title_full_unstemmed | Parameter evaluation and fully-automated radiosynthesis of [(11)C]harmine for imaging of MAO-A for clinical trials |
title_short | Parameter evaluation and fully-automated radiosynthesis of [(11)C]harmine for imaging of MAO-A for clinical trials |
title_sort | parameter evaluation and fully-automated radiosynthesis of [(11)c]harmine for imaging of mao-a for clinical trials |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337850/ https://www.ncbi.nlm.nih.gov/pubmed/25594603 http://dx.doi.org/10.1016/j.apradiso.2015.01.002 |
work_keys_str_mv | AT philippec parameterevaluationandfullyautomatedradiosynthesisof11charmineforimagingofmaoaforclinicaltrials AT zeilingerm parameterevaluationandfullyautomatedradiosynthesisof11charmineforimagingofmaoaforclinicaltrials AT mitterhauserm parameterevaluationandfullyautomatedradiosynthesisof11charmineforimagingofmaoaforclinicaltrials AT dumanicm parameterevaluationandfullyautomatedradiosynthesisof11charmineforimagingofmaoaforclinicaltrials AT lanzenbergerr parameterevaluationandfullyautomatedradiosynthesisof11charmineforimagingofmaoaforclinicaltrials AT hackerm parameterevaluationandfullyautomatedradiosynthesisof11charmineforimagingofmaoaforclinicaltrials AT wadsakw parameterevaluationandfullyautomatedradiosynthesisof11charmineforimagingofmaoaforclinicaltrials |